Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
J Pediatr Gastroenterol Nutr ; 71(4): e124-e128, 2020 10.
Artículo en Inglés | MEDLINE | ID: mdl-32810040

RESUMEN

INTRODUCTION: Recently, significant interest from families and healthcare providers has arisen to use blenderized tube feedings (BTF). Although many institutions are providing this nutritional option, literature documenting outcomes and safety is lacking. METHODS: A retrospective chart review was performed on pediatric patients receiving BTF at Rutgers-Robert Wood Johnson University Hospital between January 2013 and April 2017. Demographic data and dietary information before and after BTF were collected. Reasons for diet initiation, symptoms, and anthropometrics were recorded. Adverse events and outcomes were assessed through physician documentation and relevant medication changes. RESULTS: Thirty-five patients (24 boys) received BTF. Age at initiation of BTF ranged from 1 to 19 years (mean 8.3 +/- 5.8 [SD] years). Length of follow-up ranged from 1 to 45 months (mean 15 +/- 12.2 months). The most common reason for starting BTF was gastroesophageal reflux disease (GERD) (N = 32). Almost all patients were on medications for GERD, constipation, or gastrointestinal dysmotility before starting BTF (N = 33). Majority of patients had improvement in relevant symptoms (N = 20); 13 of 33 patients on gastrointestinal medications were able to wean or stop medication(s). BMI z scores did not differ before and after BTF initiation (P = 0.558). No serious life-threatening adverse events were found. CONCLUSIONS: Our data suggest that BTF is a safe dietary intervention that may improve gastrointestinal symptoms in pediatric patients. Further prospective studies are needed to compare safety and efficacy of BTF and commercial formulas in pediatric patients.


Asunto(s)
Nutrición Enteral , Alimentos Formulados , Adolescente , Adulto , Niño , Preescolar , Dieta , Humanos , Lactante , Masculino , Estudios Prospectivos , Estudios Retrospectivos , Adulto Joven
2.
J Pediatr Health Care ; 31(4): 506-510, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28283348

RESUMEN

Congenital glucose-galactose malabsorption (CGGM) is a rare cause of intractable infantile diarrhea, with only a few hundred cases recognized worldwide. This life-threatening disorder must be considered in the differential diagnosis of an infant who presents with diarrhea and dehydration that fails to respond to standard therapy. The clinical and diagnostic course of an infant with recurrent episodes of watery diarrhea and hypernatremic dehydration found to be homozygous for a rare variant in the SLC5A1 gene, c.187C>T (p.R63X) is described.


Asunto(s)
Errores Innatos del Metabolismo de los Carbohidratos/dietoterapia , Diarrea Infantil/dietoterapia , Carbohidratos de la Dieta/efectos adversos , Fórmulas Infantiles , Síndromes de Malabsorción/dietoterapia , Errores Innatos del Metabolismo de los Carbohidratos/complicaciones , Errores Innatos del Metabolismo de los Carbohidratos/rehabilitación , Diarrea Infantil/congénito , Diarrea Infantil/etiología , Diarrea Infantil/rehabilitación , Femenino , Alimentos Formulados , Fructosa , Asesoramiento Genético , Marcadores Genéticos , Humanos , Fenómenos Fisiológicos Nutricionales del Lactante , Recién Nacido , Síndromes de Malabsorción/complicaciones , Síndromes de Malabsorción/congénito , Síndromes de Malabsorción/rehabilitación , Eliminación de Secuencia , Transportador 1 de Sodio-Glucosa/genética , Leche de Soja
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA